These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7555469)

  • 21. Impact of physical fitness and glycemic control on in vivo insulin action in adolescents with IDDM.
    Arslanian S; Nixon PA; Becker D; Drash AL
    Diabetes Care; 1990 Jan; 13(1):9-15. PubMed ID: 2404722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.
    Schnell O; Eisfelder B; Standl E; Ziegler AG
    Diabetes; 1997 Oct; 46(10):1607-11. PubMed ID: 9313757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans.
    Davis MR; Shamoon H
    Metabolism; 1992 Feb; 41(2):216-23. PubMed ID: 1736045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.
    Kolterman OG; Schwartz S; Corder C; Levy B; Klaff L; Peterson J; Gottlieb A
    Diabetologia; 1996 Apr; 39(4):492-9. PubMed ID: 8778001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.
    Dunn FL; Nathan DM; Scavini M; Selam JL; Wingrove TG
    Diabetes Care; 1997 Jan; 20(1):59-63. PubMed ID: 9028695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
    Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
    Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic insulin action in adolescents with insulin-dependent diabetes mellitus: relationship with long-term glycemic control.
    Arslanian S; Heil BV; Kalhan SC
    Metabolism; 1993 Mar; 42(3):283-90. PubMed ID: 8487645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved blood glucose variability, HbA1c insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicenter Lispro Insulin Study.
    Johansson UB; Adamson UC; Lins PE; Wredling RA
    Diabetes Metab; 2000 May; 26(3):192-6. PubMed ID: 10880892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients.
    Luzi L; Groop LC; Perseghin G; Taskinen MR; Hilden H; Bianchi E; Terruzzi I; Dodesini AR; Di Carlo V; Pozza G
    Diabetes; 1996 Mar; 45(3):354-60. PubMed ID: 8593942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramuscular triglyceride content is increased in IDDM.
    Ebeling P; Essén-Gustavsson B; Tuominen JA; Koivisto VA
    Diabetologia; 1998 Jan; 41(1):111-5. PubMed ID: 9498639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preservation of physiological responses to hypoglycemia 2 days after antecedent hypoglycemia in patients with IDDM.
    George E; Marques JL; Harris ND; Macdonald IA; Hardisty CA; Heller SR
    Diabetes Care; 1997 Aug; 20(8):1293-8. PubMed ID: 9250457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia.
    Pampanelli S; Fanelli C; Lalli C; Ciofetta M; Sindaco PD; Lepore M; Modarelli F; Rambotti AM; Epifano L; Di Vincenzo A; Bartocci L; Annibale B; Brunetti P; Bolli GB
    Diabetologia; 1996 Jun; 39(6):677-86. PubMed ID: 8781763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy.
    Porcellati F; Fanelli C; Bottini P; Epifano L; Rambotti AM; Lalli C; Pampanelli S; Scionti L; Santeusanio F; Brunetti P
    Diabetes; 1993 Jul; 42(7):1055-64. PubMed ID: 8513972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subclinical nerve dysfunction in children and adolescents with IDDM.
    Hyllienmark L; Brismar T; Ludvigsson J
    Diabetologia; 1995 Jun; 38(6):685-92. PubMed ID: 7672490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.
    Avogaro A; Valerio A; Gnudi L; Maran A; Miola M; Duner E; Marescotti C; Iori E; Tiengo A; Nosadini R
    Diabetologia; 1992 Feb; 35(2):129-38. PubMed ID: 1547916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.